Ledger.Open graph →
SEC Form D · Amendment · filed March 14, 2025

Chimeron Bio Corp

Offering
—
Sold
$12.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Monica Coleman · Philadelphia, PAExecAntonin De Fougerolles · Philadelphia, PADirectorKevin Heyeck · Philadelphia, PAExec · DirectorAfshin Safavi · Philadelphia, PADirectorCatalyst Impact Partners, Corp · Cambridge, MAExec · DirectorMonica Coleman · Philadelphia, PAExecEdward H. O'Donnell · Houston, TXDirectorRyan Clinton · Memphis, TNDirectorJames N. Falbe · Chandler, AZExec · DirectorDennis Bethel · FRIANT, CADirectorChris Justin · NEW ORLEANS, LADirectorAdam Roter · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗